Girshick Birgit
Chief Executive Officer
Girshick Birgit has filed 7 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, Girshick Birgit is listed as Chief Executive Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Inside the rolling window, Girshick Birgit reported no open-market purchases and 1 open-market sale totaling $1.8M in CRL.
Companies traded
Other insiders at CRL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Girshick Birgit made?
Girshick Birgit has filed 7 SEC Form 4 filings (13 transaction rows) across 1 company since 2026.
Which companies does Girshick Birgit trade?
Girshick Birgit has filed SEC Form 4 disclosures for 1 company, including CRL.
When was Girshick Birgit's most recent SEC Form 4 filing?
Girshick Birgit's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is Girshick Birgit's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Girshick Birgit is listed as Chief Executive Officer.
What is Girshick Birgit's total buy and sell value in the current window?
Inside the rolling retention window, Girshick Birgit bought $0 and sold $1.8M based on SEC Form 4 filings.
What was Girshick Birgit's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,500 CRL shares on 2026-08-11, worth $1.8M, per SEC Form 4 filings.